This competition is closed. All submitted proposals will be assessed according to the process outlined in the competition timeline, and results will be announced as indicated.
Call for genomics or engineering biology start-ups solving global challenges in therapeutics, future of food, biomaterials, biological tools, diagnostics and bioinformatics/AI-based technologies
The Ontario Genomics (OG) Landing Pad Investment Program (LPIP) seeks to provide investment and support to help Ontario-based genomics and engineering biology1 companies to start and scale successfully. To enable this, OG is offering support to start-ups that attend an approved International Accelerator Program and return to Ontario upon completion. The Landing Pad Investment Program partner IndieBio (San Francisco & New York), offers a minimum of $275,000 USD upon acceptance to their program, and is backed by the global venture capital firm SOSV.
- Successful applicants will receive a $100,000 investment from Ontario Genomics
- Companies will benefit from mentorship which may include: regulatory pathway assistance, global outlook and connections, understanding of export markets, business model strategy, technical development, funding and foreign investment.
- Companies can be connected to Ontario’s leading incubators and support organizations such as Velocity, Synapse, McMaster Innovation Park and Ryerson’s SDZ.
How it works:
*Impacting at least 1B people or is part of a $1B market
Get Started
- Step 1: Contact Britney Hess, Ontario Genomics Manager, Investment and Venture Development, if you have any questions about the program or your eligibility!
- Step 2: Fill in the application form (linked above) and send it to Britney Hess by December 1, 2021.
- Step 3: Eligible top-ranked applicants will pitch to an expert panel on December 15, 2021. Top-ranked applicants will undergo a due diligence process.
- Step 4: Successful applicants will receive $100,000 in investment from Ontario Genomics, as well as opportunities for mentorship and connections to lab space.
1.Genomics can encompass proteomics, transcriptomics, epigenomics, bioinformatics and other related disciplines that involve systematic, comprehensive and high-throughput procedures to study cellular constituents and function. Engineering (or synthetic) biology is a convergence of genomics and molecular biosciences with computing, automation, miniaturization, artificial intelligence (AI), and the application of engineering principles to biological systems. See OG Engineering Biology Whitepaper for examples